Gossamer Bio

About

Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Our goal is to enhance the lives of people living with rare diseases. We’re building something special — and we’d love for you to be a part of it. Explore our current openings and see where a career at Gossamer Bio can take you.